View Author
scopus: 12777128400

Verwijnen, S.M.

(Suzanne Verwijnen)


tumor receptor imaging peptide therapy expression cancer analog study uptake patient somatostatin radiolabeled treatment vector j nucl med result glioma tissue radionuclide ad 5.tk injection gene therapy virus effect figure adenoviral brain animal tumor cells sst 2 radioactivity binding chapter infection combination hsv-tk krenning adenoviru distribution kidney transfer gene expression glioblastoma spect radionuclide therapy administration group control survival ad 5-gfa radiation kinase breeman image radiolabeled peptides 177 lu in-dtpa scintigraphy sst 2 expression analogue reubi octreotide bernard protein delivery strategy trial herpe simplex particle activity model 5-gfa 131 i hoofdstuk somatostatin receptors thymidine subtype adenoviral gene transfer




4 Most Recent Publications

Update: Improvement strategies for peptide receptor scintigraphy and radionuclide therapy (Article)
Visser, M. de Verwijnen, S.M. Jong, M. de
2008-04-01
Improvement of Malignant Glioma Treatment: Preclinical evaluation of adenoviral gene therapy and PRRT (Doctoral Thesis)
Verwijnen, S.M.
2007-12-12
Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective oncolytic adenovirus (Article)
Horst, M. ter Brouwer, E. Verwijnen, S.M. Rodijk, M. Jong, M. de Hoeben, R.C. Leeuw, B. de Smitt, P.S.
2007-12-01
Five stabilized 111in-labeled neurotensin analogs in nude mice bearing HT29 tumors (Article)
Janssen, P.J.J.M. Visser, M. de Verwijnen, S.M. Bernard, B.F. Srinivasan, A. Erion, J.L. Breeman, W.A.P. Vulto, A.G. Krenning, E.P. Jong, M. de
2007-06-01